Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth A Karron

Showing results (11-20 of 153) with videos related to

Pageof 16
Sort By:
The Journal of Infectious Diseases|November 6, 2004
Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxisJennifer L Harcourt, Ruth A Karron, Ralph A Tripp
Current Topics in Microbiology and Immunology|December 24, 2013
Live-attenuated respiratory syncytial virus vaccinesRuth A Karron, Ursula J Buchholz, Peter L Collins
BMC Pregnancy and Childbirth|March 28, 2024
Lessons learned from COVID-19 vaccine acceptance among pregnant and lactating women from two districts in Kenya to inform demand generation efforts for future maternal RSV vaccinesRupali J Limaye, Prachi Singh, Berhaun Fesshaye, et al.
Human Vaccines & Immunotherapeutics|October 9, 2023
RSV awareness, risk perception, causes, and terms: Perspectives of pregnant and lactating women in Kenya to inform demand generation efforts for maternal RSV vaccinesRupali J Limaye, Berhaun Fesshaye, Prachi Singh, et al.
The Journal of Infectious Diseases|September 23, 2016
Clinical Predictors of Critical Lower Respiratory Tract Illness Due to Respiratory Syncytial Virus in Infants and Children: Data to Inform Case Definitions for Efficacy TrialsJessica E Atwell, Sarah Geoghegan, Ruth A Karron, et al.
Clinical Pediatrics|August 9, 2002
Comparison of temple temperatures with rectal temperatures in children under two years of ageGeorge K Siberry, Marie Diener-West, Elizabeth Schappell, et al.
Pediatrics|February 5, 2002
Risk factors for severe respiratory syncytial virus infection among Alaska native childrenLisa R Bulkow, Rosalyn J Singleton, Ruth A Karron, et al.
International Journal for Equity in Health|May 7, 2025
Gender equity and COVID-19 vaccine policies for pregnant people: a global analysisEleonor Zavala, Elizabeth Doggett, Andrew Nicklin, et al.
The Journal of Infectious Diseases|December 31, 2011
Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and genderSurender Khurana, Nitin Verma, Kawsar R Talaat, et al.
The Journal of Infectious Diseases|March 14, 2013
Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokinesRuth A Karron, Bhagvanji Thumar, Elizabeth Schappell, et al.
Pageof 16

Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
The Journal of Infectious Diseases|November 6, 2004
Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxisJennifer L Harcourt, Ruth A Karron, Ralph A Tripp
Current Topics in Microbiology and Immunology|December 24, 2013
Live-attenuated respiratory syncytial virus vaccinesRuth A Karron, Ursula J Buchholz, Peter L Collins
BMC Pregnancy and Childbirth|March 28, 2024
Lessons learned from COVID-19 vaccine acceptance among pregnant and lactating women from two districts in Kenya to inform demand generation efforts for future maternal RSV vaccinesRupali J Limaye, Prachi Singh, Berhaun Fesshaye, et al.
Human Vaccines & Immunotherapeutics|October 9, 2023
RSV awareness, risk perception, causes, and terms: Perspectives of pregnant and lactating women in Kenya to inform demand generation efforts for maternal RSV vaccinesRupali J Limaye, Berhaun Fesshaye, Prachi Singh, et al.
The Journal of Infectious Diseases|September 23, 2016
Clinical Predictors of Critical Lower Respiratory Tract Illness Due to Respiratory Syncytial Virus in Infants and Children: Data to Inform Case Definitions for Efficacy TrialsJessica E Atwell, Sarah Geoghegan, Ruth A Karron, et al.
Clinical Pediatrics|August 9, 2002
Comparison of temple temperatures with rectal temperatures in children under two years of ageGeorge K Siberry, Marie Diener-West, Elizabeth Schappell, et al.
Pediatrics|February 5, 2002
Risk factors for severe respiratory syncytial virus infection among Alaska native childrenLisa R Bulkow, Rosalyn J Singleton, Ruth A Karron, et al.
International Journal for Equity in Health|May 7, 2025
Gender equity and COVID-19 vaccine policies for pregnant people: a global analysisEleonor Zavala, Elizabeth Doggett, Andrew Nicklin, et al.
The Journal of Infectious Diseases|December 31, 2011
Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and genderSurender Khurana, Nitin Verma, Kawsar R Talaat, et al.
The Journal of Infectious Diseases|March 14, 2013
Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokinesRuth A Karron, Bhagvanji Thumar, Elizabeth Schappell, et al.
Pageof 16